WebJan 27, 2024 · 28th January 2024: Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) (“CannPal” or “the Company”) is pleased to update the market on its progress in the December 2024 ... WebNov 8, 2024 · According to our data, CannPal Animal Therapeutics Limited has a market capitalization of AU$9.8m, and paid its CEO total annual compensation worth AU$244k over the year to June 2024. That's just...
Regulations - CannPal
WebCannPal Animal Therapeutics Limited (ASX: CP1) is a pharmaceutical-focused animal health Company researching the benefits of medical cannabis for companion animals. CannPal is researching and developing medicines derived from cannabinoids to provide veterinarians w Read More Contact Who is CannPal Headquarters WebMar 22, 2024 · CannPal Animal Therapeutics Limited (ASX: CP1) - Share Price and Research DELISTED - Current share price for CP1 : $0.170 Overview Research Company Financials Company Announcements Dividends Change in Directors' Interest Share Price Float CP1 General Information + Prices as at 16:35, 22 Mar 2024 shuga shack wilmington nc
CannPal - Overview, News & Competitors ZoomInfo.com
WebNov 21, 2024 · CannPal Animal Therapeutics Ltd ( ASX:CP1) director Max Johnston has shown confidence in the company’s development of cannabis-derived medications for animals by acquiring shares on-market. Johnson, a non-executive director, has this week acquired more than 35,600 shares with a total value of almost $5,000. WebCannPal Animal Therapeutics Limited (CP1) was incorporated on 3rd June 2016. CannPal was founded by a team of experienced executives to establish a new standard of care in … WebMar 22, 2024 · CannPal Animal Therapeutics Limited (CP1) Changes in Directors' Interest & Trades. See all changes in directors' interest & trades for CannPal Animal … shuga season 5